awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38533619-2D1E584B-0BBE-4756-A181-43FA27A1FDE1
Q38533619-2D1E584B-0BBE-4756-A181-43FA27A1FDE1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38533619-2D1E584B-0BBE-4756-A181-43FA27A1FDE1
Hepatitis C virus drug resistance-associated substitutions: State of the art summary.
P2860
Q38533619-2D1E584B-0BBE-4756-A181-43FA27A1FDE1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38533619-2D1E584B-0BBE-4756-A181-43FA27A1FDE1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e920d8875b2ed21e4baf850fbb9f7d3675ea7f6
P2860
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.